Pfizer (PFE) Net Income (QoQ) (2009 - 2024)
Pfizer (PFE) Net Income (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 29, 2024 | -147.06% |
| Jun 30, 2024 | 440.00% |
| Mar 31, 2024 | 80.77% |
| Dec 31, 2023 | -316.67% |
| Oct 1, 2023 | 700.00% |
| Jul 2, 2023 | -300.00% |
| Oct 2, 2022 | -161.76% |
| Jul 3, 2022 | 477.78% |
| Oct 3, 2021 | 94.49% |
| Jul 4, 2021 | -23,700.00% |
| Sep 27, 2020 | -37.29% |
| Jun 28, 2020 | 1.36% |
| Mar 29, 2020 | -83.42% |
| Dec 31, 2019 | 132,750.00% |
| Dec 31, 2018 | 66,427.27% |
| Apr 1, 2018 | -150.00% |
| Dec 31, 2015 | -350.00% |
| Sep 27, 2015 | 700.00% |
| Jun 28, 2015 | -80.00% |
| Mar 29, 2015 | 133.33% |